Search Results - "Ozbay, A.B."

Higher and rising prevalence and incidence of renal impairment and chronic kidney disease in chronic hepatitis B patients compared to matched non-chronic hepatitis B controls in the United States: results of a real-world analysis by Nguyen, M.H, Lim, J, Liou, I, Ozbay, A.B, Fraysse, J, Meyer, N, Dusheiko, G, Gordon, S

Get full text

Prevalence of osteoporosis and bone fracture was 2-fold higher in chronic hepatitis B compared to non-chronic hepatitis B patients and continued to increase in the last decade: results of a United States population-based cohort study by Gordon, S.C, Lim, J, Liou, I, Ozbay, A.B, Moore-Schiltz, L, Dusheiko, G, Nguyen, M.H

Get full text

3 times higher healthcare cost in chronic hepatitis B patients compared to non-chronic hepatitis B controls especially those with decompensated liver disease: United States real world healthcare utilization and cost analysis by Nguyen, M.H, Lim, J, Ozbay, A.B, Shreay, S, Liou, I, Meyer, N, Dusheiko, G, Gordon, S

Get full text

Advancing age and comorbidities in chronic hepatitis B patients: results of 10-year longitudinal analysis of a diverse population-based cohort of 44,026 chronic hepatitis B patients in the United States by Nguyen, M.H, Lim, J, Ozbay, A.B, Fraysse, J, Liou, I, Meyer, N, Dusheiko, G, Gordon, S

Get full text

Rising healthcare utilization and cost of chronic hepatitis B: real-world analysis of 44,026 chronic hepatitis B patients and 121,568 matched non-chronic hepatitis B controls in the United States by Lim, J, Nguyen, M, Liou, I, Ozbay, A.B, Moore-Schiltz, L, Dusheiko, G, Gordon, S

Get full text

Burden of acute kidney injury following high risk cardiac surgery by Dasta, J.F, Marshall, T, Ozbay, A.B, Hayes, O.A, Khan, S

Get full text

EE269 Cost-Effectiveness of Profile Omission of Local Adjuvant Radiotherapy (POLAR), A Novel Genomic Signature, after Breast Conserving Surgery for Women with Invasive Early-Stage Breast Cancer (ESBC) by Alagoz, O., Arrick, B., Speers, C., Ward, M., King, T., Bennett, J., Ozbay, A.B., Le, Q.

Get full text

EPH232 The Large Hidden Prevalence Rate of Cancer Using Backward Induction Method Reveals Screening Opportunity in Earlier Stages by ElHabr, A.K., Tyson, C., Cao, X., Merdan, S., Raoof, S., Ozbay, A.B., Limburg, P., Beer, T.M., Deshmukh, A.A., Chhatwal, J.

Get full text

EE508 Cost of Liver Cancer Screening in Patients with Cirrhosis by Samur, S., Rustgi, V.K., Parikh, N.D., Yang, J.D., Roberts, L.R., Nguyen, M.H., Ozbay, A.B., Ayer, T., Singal, A.G., Chhatwal, J.

Get full text

PMD22 Cross-Sectional Adherence with the Multi-Target Stool DNA Test for Colorectal Cancer Screening in a Medicaid Population by Miller-Wilson, L.A., Finney, Rutten LJ, Van, Thomme J, Ozbay, A.B., Limburg, P.J.

Get full text

PCN145 THE IMPACT OF INCREASING MT-SDNA USE AMONG COLORECTAL CANCER SCREENERS IN A US EMPLOYER POPULATION by Hathway, J., Miller-Wilson, L.A., Jensen, I., Ozbay, A.B., Regan, C., Yao, W., Jena, A.B., Weinstein, M.C., Parks, P.

Get full text

PCN289 ESTIMATING THE IMPACT OF IMPERFECT ADHERENCE TO STOOL-BASED COLORECTAL CANCER SCREENING STRATEGIES ON COMPARATIVE EFFECTIVENESS USING THE CRC-AIM MICROSIMULATION MODEL by Piscitello, A., Saoud, L., Fendrick, A.M., Borah, B., Hassmiller Lich, K., Matney, M., Ozbay, A.B., Parton, M., Limburg, P.J.

Get full text

PCN148 BUDGET IMPACT OF IMPROVING ADHERENCE TO COLORECTAL CANCER SCREENING by Hathway, J., Miller-Wilson, L.A., Jensen, I., Ozbay, A.B., Regan, C., Yao, W., Jena, A.B., Weinstein, M.C., Parks, P.

Get full text

PCN280 IMPACT OF ALIGNED SCREENING INTERVAL ON SCREENING OUTCOMES USING THE CRC-AIM MICROSIMULATION MODEL by Saoud, L., Piscitello, A., Fendrick, A.M., Borah, B., Hassmiller Lich, K., Matney, M., Ozbay, A.B., Parton, M., Limburg, P.J.

Get full text

Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) patients with advanced liver disease had high burden of comorbidities, healthcare resource utilization (HCRU) and costs: results from Italian administrative databases by Marchesini, G., Ting, J., Saragoni, S., Esposti, L. Degli, Ozbay, A.B., Petta, S.

Get full text

THU-178 - Rising healthcare utilization and cost of chronic hepatitis B: real-world analysis of 44,026 chronic hepatitis B patients and 121,568 matched non-chronic hepatitis B controls in the United States by Lim, J., Nguyen, M., Liou, I., Ozbay, A.B., Moore-Schiltz, L., Dusheiko, G., Gordon, S.

Get full text

SAT-132 - Higher and rising prevalence and incidence of renal impairment and chronic kidney disease in chronic hepatitis B patients compared to matched non-chronic hepatitis B controls in the United States: results of a real-world analysis by Nguyen, M.H., Lim, J., Liou, I., Ozbay, A.B., Fraysse, J., Meyer, N., Dusheiko, G., Gordon, S.

Get full text

PS-109 - Prevalence of osteoporosis and bone fracture was 2-fold higher in chronic hepatitis B compared to non-chronic hepatitis B patients and continued to increase in the last decade: results of a United States population-based cohort study by Gordon, S.C., Lim, J., Liou, I., Ozbay, A.B., Moore-Schiltz, L., Dusheiko, G., Nguyen, M.H.

Get full text

FRI-005 - 3 times higher healthcare cost in chronic hepatitis B patients compared to non-chronic hepatitis B controls especially those with decompensated liver disease: United States real world healthcare utilization and cost analysis by Nguyen, M.H., Lim, J., Ozbay, A.B., Shreay, S., Liou, I., Meyer, N., Dusheiko, G., Gordon, S.

Get full text

PS-107 - Advancing age and comorbidities in chronic hepatitis B patients: results of 10-year longitudinal analysis of a diverse population-based cohort of 44,026 chronic hepatitis B patients in the United States by Nguyen, M.H., Lim, J., Ozbay, A.B., Fraysse, J., Liou, I., Meyer, N., Dusheiko, G., Gordon, S.

Get full text